News Notification

The Brigham and Dana-Farber Board Review in Hematology and Oncology 2020

2271 views Tags: Brigham Board Review CME

Elevate Your Hematology and Oncology

The Brigham and Dana-Farber Board Review in Hematology and Oncology will help improve clinical practice gaps in hematology and oncology derived from the American Board of Internal Medicine (ABIM) certification/recertification requirements. In this CME program, expert speakers address relevant topics in case-based board review presentations. Improve patient care by learning to:

  • Perform differential diagnosis of complex hematologic and oncologic disorders
  • Identify and apply current therapeutic options for hematologic and oncologic disorders
  • Evaluate and interpret up-to-date literature relevant to hematology and oncology
  • Illustrate knowledge of pathophysiology of hematologic and oncologic disorders
  • Apply new knowledge to the ABIM certification/recertification hematology and oncology examinations

* Date of Original Release: April 15, 2020

Learning Objectives

At the conclusion of this activity, the participant will be able to:

  • Apply current/recommended Hematology and Oncology guidelines in clinical practice
  • Perform differential diagnosis of complex clinical presentations related to Hematologic and Oncologic disorders
  • Identify/apply current therapeutic options for specific Hematologic and Oncologic disorders
  • Review and interpret up-to-date literature relevant to clinical practice in Hematology and Oncology
  • Demonstrate knowledge of pathophysiology as it applies to management of Hematology and Oncology disorders
  • Apply knowledge gained to the ABIM Certification/Recertification Hematology and Oncology examinations

THE BRIGHAM AND DANA-FARBER BOARD REVIEW IN MEATOLOGY AND ONCOLOGY

0 0 votes
Article Rating

THE BRIGHAM AND DANA-FARBER BOARD REVIEW IN MEATOLOGY AND ONCOLOGY TOPICS

CHECK SAMPLES

1. Molecular Genetics of Cancer – Nikhil Wagle, MD

2. Advances in Cancer Drug Development – Geoffrey I. Shapiro, MD, PhD

3. Infections in Cancer Patients – Lindsey Baden, MD

4. Symptom Management in Patients with Cancer – Andrew J. Lawton, MD

5. Communication: The Key to Excellence in End-of-Life Care – Rachelle E. Bernacki, MD

6. Biology of Hematopoietic Stem Cell Transplantation – Robert J. Soiffer, MD

7. Biology of Acute Leukemia and Myelodysplastic Syndromes – Benjamin L. Ebert, MD, PhD

8. Acute Leukemias – Daniel J. DeAngelo, MD, PhD

9. Myelodysplastic Syndrome – David P. Steensma, MD

10. Chronic Myelogenous Leukemia – Marlise R. Luskin, MD

11. Myeloproliferative Syndromes – Ann M. Mullally, MD

12. Multiple Myeloma – Kenneth C. Anderson, MD

13. Waldenstrom Macroglobulemia and Amyloidosis – Jorge J. Castillo, MD

14. Low Grade Lymphomas – Caron A. Jacobson, MD

15. High Grade Lymphomas – Eric D. Jacobsen, MD

16. Hodgkin’s Lymphoma – Jennifer L. Crombie, MD

17. Diagnosis and Treatment of CLL and Related B Cell Malignancies – Matthew S. Davids, MD

18. Head and Neck Cancer – Robert I. Haddad, MD

19. Natural History, Screening, Surgery and Small Cell Lung Cancer – Bruce E. Johnson, MD

20. Non Small Cell Lung Cancer – Mark Awad, MD, PhD

21. Mesothelioma and Thymoma – David M. Jackman, MD

22. Thyroid Cancer – Jochen Lorch, MD

23. Carcinoid and Pancreatic Neuroendocrine Tumors – Jennifer Ang Chan, MD

24. Esophageal and Gastric Cancer – Peter C. Enzinger, MD

25. Pancreatic and Hepatobiliary Cancer – Brian M. Wolpin, MD

26. Anal Cancers – Robert J. Mayer, MD

27. Colorectal Cancers – Robert J. Mayer, MD

28. Gastrointestinal Cancer: Genetic Syndromes – Matthew Yurgelun, MD

29. Germ Cell Tumor: Maximizing Cure While Minimizing the Burden of Therapy – Mark M. Pomerantz, MD

30. Renal and Bladder Cancer – Guru P. Sonpavde, MBBS

31. Prostate Cancer Part I: Overview and Management of Localized Disease – Atish D. Choudhury, MD, PhD

32. Prostate Cancer Part II: Management of Disseminated Prostate Cancer – Atish D. Choudhury, MD, PhD

33. Melanoma – F. Stephen Hodi, MD

34. Sarcomas and Gastrointestinal Stromal Tumors (GIST) – George D. Demetri, MD

35. Ovarian Cancer – Ursula A. Matulonis, MD

36. Cervical and Endometrial Cancer – Panagiotis A. Konstantinopoulos, MD, PhD

37. Neuro-oncology – David A. Reardon, MD

38. Breast Cancer: Risk Factors, Genetics, Screening, and Prevention – Judy E. Garber, MD, MPH

39. Multimodality Therapy for Early Stage Breast Cancer: Part 1 – Surgery and Radiation – Harold J. Burstein, MD, PhD

40. Multimodality Therapy for Early Stage Breast Cancer: Part 2 – Systemic Therapy – Harold J. Burstein, MD, PhD

41. Management of Metastatic Breast Cancer – Erica Mayer, MD, MPH

42. Breast Cancer Survivorship – Ann H. Partridge, MD, MPH

43. Hematopoiesis and Cytokines – David T. Scadden, MD

44. Acquired Bone Marrow Failure – Julie-Aurore Losman, MD, PhD

45. Congenital Bone Marrow Failure – Akiko Shimamura, MD, PhD

46. Hemophagocytic Syndromes and Related Immunodeficiencies – Barbara A. Degar, MD

47. Anemia: An Overview – Ronald P. McCaffrey, MD

48. Iron Deficiency and Iron Overload – Mark D. Fleming, MD, PhD

49. Immune Hemolytic Anemia – Richard M. Kaufman, MD

50. Non-immune Hemolytic Anemia – David E. Golan, PhD, MD

51. Sickle Cell Disease – Maureen M. Achebe, MD, MPH

52. Thalassemia and Other Hemoglobinopathies – Matthew M. Heeney, MD

53. Disorders of Neutrophils – Nancy Berliner, MD

54. Acquired Thrombocytopenias – Elisabeth M. Battinelli, MD, PhD

55. Hemophilia – Aric D. Parnes, MD

56. Von Willebrand Disease and Congenital Platelet Disorders – Nathan T. Connell, MD, MPH

57. Congenital and Acquired Thrombophilia – Kenneth A. Bauer, MD

58. Use of Direct Oral Anticoagulants in Clinical Practice – Jean M. Connors, MD

59. Transfusion Medicine for the Clinician – Walter H. Dzik, MD

Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments
error: Content is protected !!